Newgenivf Group Limited cash flow statement NIVFW
In fiscal 2025, which ended Dec 31, 2025, Newgenivf Group Limited used $10.9 million of cash from operations, down 32.2% from the year before. It spent $135,025 on capital expenditures. Free cash flow was negative, at -$11.1 million.
USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.
| Line |
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
|---|---|---|---|
| Operating | |||
| Depreciation and amortization |
0
+864.6%
|
0
-37.4%
|
0
|
| Operating cash flow |
-11
-32.2%
|
-8
-367.9%
|
-2
|
| Investing | |||
| Capital expenditures |
0
+154.5%
|
0
-24.1%
|
0
|
| Investing cash flow |
-8
-14151.6%
|
-0
+24.1%
|
-0
|
| Financing | |||
| Financing cash flow |
19
+118.9%
|
9
+361.1%
|
2
|
| Change in cash | |||
| Effect of exchange rate |
-0
-558.2%
|
0
+337.1%
|
-0
|
| Free cash flow |
-11
-33.0%
|
-8
-353.0%
|
-2
|
| Per share | |||
| Free cash flow per share |
-3.40
+100.0%
|
-69,891.76
+61.9%
|
-183,598.30
|
| Ratios | |||
| Free cash flow margin |
-46.65%
|
-2,237.79%
|
-35.75%
|
| Capital expenditures to revenue |
0.57%
|
14.27%
|
1.36%
|
| Cash conversion |
-1.11x
|
—
|
-13.57x
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.
Company profile
- Industry
- Services-Misc Health & Allied Services, NEC (SIC 8090)
- Listed as
- NIVF (Nasdaq), NIVFW (Nasdaq)
- Incorporated in
- Virgin Islands, British
- Headquarters
- Bangkok, Thailand
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1981662
- Former names
- ASPAC I Mini Acquisition Corp. (until Mar 1, 2024)
Other Services-Misc Health & Allied Services, NEC companies
- Fresenius Medical Care AG FMS
- Davita Inc. DVA
- Sotera Health Co SHC
- Progyny, Inc. PGNY
- agilon health, inc. AGL
- Charming Medical Ltd MCTA
- Viemed Healthcare, Inc. VMD
- Park Dental Partners, Inc. PARK
All 15 Services-Misc Health & Allied Services, NEC companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.